Fact CheckerSign in

NCT06183723Enrolling by invitation

Optimizing Care for Challenging People Living With HIV

Feasible Program of Sustainable Medical Care for People Living With HIV Who Are Difficult to Treat or Marginalized in Taiwan

Source: ClinicalTrials.gov · Last updated 8 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Conduct an intervention combining social and behavioral health models with digital health technologies to improve their adherence to their medication schedules. The success of the intervention is assessed by comparing adherence rates before and after its implementation to see if there's a notable enhancement in how well patients follow their antiretroviral therapy.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
210 (estimated)
First submitted
6 Dec 2023
Start date
18 Mar 2024
Primary completion date
31 Dec 2025
Lead sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Diseases
HIV
NCT number
NCT06183723

What you commit to

  • Study type: Interventional
  • Planned participants: 210
  • From 18 Mar 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Less than 365 days from the initial use of antiretroviral drugs to the assessment for inclusion in the study.
  • Inability to obtain complete medication records for the 365 days prior to inclusion.

Age

  • Under 18 years of age.

Other

  • Illiterate.
  • Non-consenting individuals.
  • Lack of a smart phone.
  • No willingness to return for follow-up at the participating hospital.

Who the study is looking for

  • 1\. PLWH with adherence below the specific proportion of days covered (PDC), which is defined as the specific level that corresponds to 90% at viral suppression (\< 200 copies/mL).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kaohsiung Medical University Chung-Ho Memorial Hospital
Coordinator of this site? Confirm its status
Kaohsiung CityTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.